202 - Becoming an Expert in the Work Nobody Wants to Do/Design, Risk, and the Messy Middle of Combination Products w/Joey Frechin

Let's Combinate · 20 Aug 2025 · 32m

What this episode covers

Joey Frechin, a Senior Technical Program Manager in med tech consulting, explains the complexities of aligning risk assessments for combination products, noting that while drug and device teams are starting to integrate their processes, significant methodological gaps remain. He details the P1/P2 probability scoring methodology used in ISO 14971 to distinguish between device failure and patient harm, and shares his career strategy of becoming an expert in 'unwanted' but high-value tasks like DFMEA and PFMEA to bridge engineering and quality teams. Frechin also discusses current industry trends, where companies often pivot from complex bespoke designs to simplified or off-the-shelf subsystems to meet clinical trial timelines, highlighting the critical importance of early sterilization and accelerated aging testing to avoid late-stage failures.

Other shows on the same ground, closest first.

  • Global Medical Device Podcast · 1h 03m

    #422: ISO 14971 and the Road to Risk Management with Edwin Bills

    Edwin Bills, a lead expert in medical device risk management and key contributor to ISO 14971, explains how his background as a submariner and manufacturing quality engineer informs his approach to patient safety and cost of quality. He details the critical link between manufacturing process capability (CPK), supplier quality, and financial risk, arguing that quality failures directly impact a company's bottom line and reputation. Bills critiques common industry practices, such as late-stage FMEA and manual spreadsheet-based traceability, advocating for early hazard analysis, industrial statistics, and integrated software solutions to manage complex risks in medical devices and combination products.

  • Global Medical Device Podcast · 36m

    #325 The Role of dFMEAs in Risk Management for Medical Devices

    Wade Schroeder, a medical device expert at Greenlight Guru, explains how dFMEA and ISO 14971 work together to manage risk in medical device design. He argues that while dFMEA provides a useful bottom-up technical view, ISO 14971 offers a necessary top-down, patient-focused strategy that maps directly to FDA expectations. Schroeder highlights Greenlight Guru’s software as a tool that integrates risk management with design controls, reducing the complexity of maintaining separate systems. The discussion emphasizes using tools like fault tree analysis and fishbone diagrams to ensure comprehensive safety without compromising regulatory compliance.

  • Global Medical Device Podcast · 40m

    Inside Look into ISO 14971:2019 & ISO TR 24971:2020 from the Author's Point of View

    Ed Bills, a risk management consultant and technical committee member for ISO 14971:2019 and ISO TR 24971:2020, joins host Jon Speer to explain the nuances of the updated international medical device risk management standards. They discuss the separation of guidance from requirements, the critical role of post-market surveillance in Clause 10, and the regulatory landscape involving the EU MDR and IVDR. Bills emphasizes that risk management is a product safety standard distinct from business or project risk, and advises companies to read the full rationale and technical report to avoid common misinterpretations.

  • Global Medical Device Podcast · 35m

    #467: Combination Product Compliance: PMOA, 21 CFR Part 4 & QMS Alignment

    Jim Fentress, Director of Regulatory Affairs at Galero (a Santa Group company), explains the regulatory complexities of combination products, focusing on how the Primary Mode of Action (PMOA) dictates FDA oversight. He details the challenges pharmaceutical companies face when integrating device Quality Management Systems (QMSR/ISO 13485) into their existing CGMP frameworks under 21 CFR Part 4. The discussion covers specific friction points like risk management alignment (AAMI TIR105 vs. ICH Q9), labeling classifications, and the critical need for transparent change control protocols between device manufacturers and pharma partners.

  • Global Medical Device Podcast · 44m

    #384: Insights from an Ex-FDA Investigator: Compliance, Quality Systems, and MedTech Trends

    Vincent Cafiso, Director of Quality and Regulatory Services at Creo Consulting and former FDA investigator, discusses the critical need for MedTech companies to align R&D testing environments with production standards to avoid costly rework and data rejection. He highlights common pitfalls in design controls, such as missing real-time aging data and inadequate documentation in Design History Files, urging companies to integrate quality validation early in the development process. Cafiso also emphasizes the importance of management responsibility and breaking down organizational silos through skip-level meetings to maintain a collaborative, startup-like culture as companies scale from garage startups to enterprise levels.

The summary, chapters and topics are generated from the episode’s audio by this directory, not written by Let's Combinate. The episode itself belongs to its publisher.